BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sagnelli E, Pisaturo M, Martini S, Filippini P, Sagnelli C, Coppola N. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World J Hepatol 2014; 6(6): 384-393 [PMID: 25018849 DOI: 10.4254/wjh.v6.i6.384]
URL: https://www.wjgnet.com/1948-5182/full/v6/i6/384.htm
Number Citing Articles
1
Jemal Alemu, Balako Gumi, Aster Tsegaye, Abdulaziz Abubeker, Fisihatsion Tadesse, Abel Shewaye, Ziyada Rahimeto, Adane Mihret, Andargachew Mulu, Amha Gebremedhin, Rawleigh Howe. Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional studyInfectious Agents and Cancer 2023; 18(1) doi: 10.1186/s13027-023-00519-6
2
Jose Ignacio Vargas, Daniela Jensen, Valeska Sarmiento, Felipe Peirano, Pedro Acuña, Felipe Fuster, Sabrina Soto, Rodrigo Ahumada, Marco Huilcaman, Mario Bruna, Werner Jensen, Francisco Fuster. Presence of anti‐HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in ChileJournal of Medical Virology 2016; 88(4): 639 doi: 10.1002/jmv.24384
3
Mohammad Hossein Ahmadi, Zohreh Sharifi, Ali Ghasemi, Sadegh Abbasian. Occult hepatitis B in Iranian blood donors, an overview of the challenges: A narrative reviewHealth Science Reports 2023; 6(8) doi: 10.1002/hsr2.1466
4
Jiaying Wu, Jiayao He, Hongmei Xu. Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysisAnnals of Hepatology 2024; 29(1): 101158 doi: 10.1016/j.aohep.2023.101158
5
Nicola Coppola, Lorenzo Onorato, Caterina Sagnelli, Evangelista Sagnelli, Italo F. Angelillo. Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver diseaseMedicine 2016; 95(30): e4311 doi: 10.1097/MD.0000000000004311
6
H. Wang, R. Swann, E. Thomas, H. A. Innes, H. Valerio, P. C. Hayes, S. Allen, S. T. Barclay, D. Wilks, R. Fox, D. Bhattacharyya, N. Kennedy, J. Morris, A. Fraser, A. J. Stanley, R. Gunson, P. G. Mclntyre, A. Hunt, S. J. Hutchinson, P. R. Mills, J. F. Dillon. Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population‐level analysisJournal of Viral Hepatitis 2018; 25(8): 930 doi: 10.1111/jvh.12897
7
Mariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, Nicola Coppola. Prevalence of occult HBV infection in Western countriesJournal of Medical Virology 2020; 92(12): 2917 doi: 10.1002/jmv.25867
8
Claudia Bozza, Marika Cinausero, Donatella Iacono, Fabio Puglisi. Hepatitis B and cancer: A practical guide for the oncologistCritical Reviews in Oncology/Hematology 2016; 98: 137 doi: 10.1016/j.critrevonc.2015.10.017
9
A. Marrone, N. Capoluongo, C. D'Amore, M. Pisaturo, M. Esposito, S. Guastafierro, I. Siniscalchi, M. Macera, A. Boemio, L. Onorato, L. Rinaldi, C. Minichini, L. E. Adinolfi, E. Sagnelli, L. Mastrullo, N. Coppola. Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapyJournal of Viral Hepatitis 2018; 25(2): 198 doi: 10.1111/jvh.12802
10
Mariantonietta Pisaturo, Giovanni Di Caprio, Federica Calò, Federica Portunato, Salvatore Martini, Nicola Coppola. Management of HBV reactivation in non-oncological patientsExpert Review of Anti-infective Therapy 2018; 16(8): 611 doi: 10.1080/14787210.2018.1505501
11
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its preventionWorld Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
12
Evangelista Sagnelli, Loredana Alessio, Caterina Sagnelli, Luciano Gualdieri, Mariantonietta Pisaturo, Carmine Minichini, Giovanni Di Caprio, Mario Starace, Lorenzo Onorato, Margherita Macera, Gaetano Scotto, Nicola Coppola. Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern ItalyHepatitis Monthly 2017; 17(8) doi: 10.5812/hepatmon.13260
13
Anna Felis-Giemza, Marzena Olesińska, Katarzyna Świerkocka, Ewa Więsik-Szewczyk, Ewa Haładyj. Treatment of rheumatic diseases and hepatitis B virus coinfectionRheumatology International 2015; 35(3): 385 doi: 10.1007/s00296-014-3195-8
14
Junichi Muraishi, Michihiko Shibata, Yuichi Honma, Masaaki Hiura, Shintaro Abe, Masaru Harada. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant LymphomaInternal Medicine 2017; 56(15): 1967 doi: 10.2169/internalmedicine.56.8233
15
Fujiko Mitsumoto-Kaseida, Masayuki Murata, Koji Takayama, Kazuhiro Toyoda, Eiichi Ogawa, Norihiro Furusyo, Jun Hayashi. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patientsJournal of Infection and Chemotherapy 2020; 26(1): 28 doi: 10.1016/j.jiac.2019.06.003
16
Bahiddin Yilmaz, Dilek Erdem, Fatih Teker, Ibrahim Goren, Beytullah Yildirim, Engin Kut, Derya Sarikaya, Memis H Atay, Idris Yucel. The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumoursJournal of International Medical Research 2016; 44(3): 627 doi: 10.1177/0300060516638992
17
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, Mariantonietta Pisaturo, Loredana Alessio, Stefania De Pascalis, Evangelista Sagnelli, Nicola Coppola. COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of LiteraturePathogens 2022; 11(7): 816 doi: 10.3390/pathogens11070816
18
Diana Gabriela Iacob, Monica Luminos, Otilia Elisabeta Benea, Ana-Maria Tudor, Cristina Mihaela Olariu, Simona Alexandra Iacob, Simona Ruta. Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scoresFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.888050
19
Angelica Maldonado-Rodriguez, Ana Maria Cevallos, Othon Rojas-Montes, Karina Enriquez-Navarro, Ma Teresa Alvarez-Muñoz, Rosalia Lira. Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significanceWorld Journal of Hepatology 2015; 7(2): 253-260 doi: 10.4254/wjh.v7.i2.253
20
Ranjit Chauhan, Shilpa Lingala, Chiranjeevi Gadiparthi, Nivedita Lahiri, Smruti R Mohanty, Jian Wu, Tomasz I Michalak, Sanjaya K Satapathy. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in managementWorld Journal of Hepatology 2018; 10(3): 352-370 doi: 10.4254/wjh.v10.i3.352
21
K. C. K. Lau, C. Osiowy, E. Giles, B. Lusina, G. van Marle, K. W. Burak, C. S. Coffin. Deep sequencing shows low‐level oncogenic hepatitis B virus variants persists post–liver transplant despite potent anti‐HBV prophylaxisJournal of Viral Hepatitis 2018; 25(6): 724 doi: 10.1111/jvh.12860
22
Caterina Sagnelli, Massimo Ciccozzi, Loredana Alessio, Eleonora Cella, Luciano Gualdieri, Mariantonietta Pisaturo, Carmine Minichini, Giovanni Di Caprio, Mario Starace, Lorenzo Onorato, Mara Capoprese, Laura Occhiello, Silvia Angeletti, Gaetano Scotto, Margherita Macera, Evangelista Sagnelli, Nicola Coppola. HBV molecular epidemiology and clinical condition of immigrants living in ItalyInfection 2018; 46(4): 523 doi: 10.1007/s15010-018-1153-1
23
E. Ghrenassia, E. Mariotte, E. Azoulay. Annual Update in Intensive Care and Emergency Medicine 2018Annual Update in Intensive Care and Emergency Medicine 2018; : 579 doi: 10.1007/978-3-319-73670-9_43
24
J.A. Cuenca-Gómez, J. Salas-Coronas, M.J. Soriano-Pérez, J. Vázquez-Villegas, A.B. Lozano-Serrano, M.T. Cabezas-Fernández. Viral hepatitis and immigration: A challenge for the healthcare systemRevista Clínica Española (English Edition) 2016; 216(5): 248 doi: 10.1016/j.rceng.2016.02.002
25
Gabriele Fabbri, Ilaria Mastrorosa, Alessandra Vergori, Valentina Mazzotta, Carmela Pinnetti, Susanna Grisetti, Mauro Zaccarelli, Adriana Ammassari, Andrea Antinori. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literatureBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2287-y
26
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatmentJournal of Viral Hepatitis 2016; 23(12): 1027 doi: 10.1111/jvh.12583
27
Yu. O. Ostankova, A. V. Semenov, E. B. Zueva, A. A. Totolian. THE PREVALENCE OF OCCULT HEPATITIS B AMONG HBSAG-NEGATIVE PERSONS WITH HIV IN VELIKY NOVGORODHIV Infection and Immunosuppressive Disorders 2019; 11(1): 64 doi: 10.22328/2077-9828-2019-11-1-64-70
28
Edina Amponsah‐Dacosta, Selokela G. Selabe, Maphahlaganye J. Mphahlele. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co‐infected patientsJournal of Medical Virology 2018; 90(2): 291 doi: 10.1002/jmv.24956
29
J.A. Cuenca-Gómez, J. Salas-Coronas, M.J. Soriano-Pérez, J. Vázquez-Villegas, A.B. Lozano-Serrano, M.T. Cabezas-Fernández. Hepatitis virales e inmigración: un reto para el sistema sanitarioRevista Clínica Española 2016; 216(5): 248 doi: 10.1016/j.rce.2016.02.005
30
Awa Abdul Carimo, Eduardo Samo Gudo, Cremildo Maueia, Nédio Mabunda, Lúcia Chambal, Adolfo Vubil, Ana Flora, Francisco Antunes, Nilesh Bhatt, Pierre Roques. First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, MozambiquePLOS ONE 2018; 13(1): e0190775 doi: 10.1371/journal.pone.0190775
31
D. Candotti, L. Boizeau, S. Laperche. Occult hepatitis B infection and transfusion-transmission riskTransfusion Clinique et Biologique 2017; 24(3): 189 doi: 10.1016/j.tracli.2017.06.014
32
Katrin Busch, Robert Thimme. Natural history of chronic hepatitis B virus infectionMedical Microbiology and Immunology 2015; 204(1): 5 doi: 10.1007/s00430-014-0369-7
33
Mariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo, Paolo Chiodini, Nicola Coppola. An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta‐analysisJournal of Viral Hepatitis 2020; 27(4): 415 doi: 10.1111/jvh.13248
34
C. Sagnelli, M. Macera, M. Pisaturo, R. Zampino, M. Coppola, E. Sagnelli. Occult HBV infection in the oncohematological settingInfection 2016; 44(5): 575 doi: 10.1007/s15010-016-0891-1
35
Evangelista Sagnelli, Margherita Macera, Antonio Russo, Nicola Coppola, Caterina Sagnelli. Epidemiological and etiological variations in hepatocellular carcinomaInfection 2020; 48(1): 7 doi: 10.1007/s15010-019-01345-y
36
R. Orlando, M. Foggia, A. E. Maraolo, S. Mascolo, G. Palmiero, O. Tambaro, G. Tosone. Prevention of hepatitis B virus infection: from the past to the futureEuropean Journal of Clinical Microbiology & Infectious Diseases 2015; 34(6): 1059 doi: 10.1007/s10096-015-2341-x
37
Pilar López-Serrano, Elsa de la Fuente Briongos, Elisa Carrera Alonso, Jose Lázaro Pérez-Calle, Conrado Fernández Rodríguez. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapyWorld Journal of Hepatology 2015; 7(3): 539-547 doi: 10.4254/wjh.v7.i3.539
38
Ali Mussa, Nor Hayati Ismail, Nazmul Huda Syed, Mustafa Talib, Alaa Siddig, Rosline Hassan, Rohimah Mohamud, Nik Haszroel Hysham Nik Hashim. Immune response to occult hepatitis B virus infection among hemodialysis patients: A reviewThe Microbe 2024; 5: 100176 doi: 10.1016/j.microb.2024.100176
39
Min-Sun Kwak, Yoon Jun Kim. Occult hepatitis B virus infectionWorld Journal of Hepatology 2014; 6(12): 860-869 doi: 10.4254/wjh.v6.i12.860
40
Claire Pierra Rouviere, Cyril B. Dousson, John E. Tavis. HBV replication inhibitorsAntiviral Research 2020; 179: 104815 doi: 10.1016/j.antiviral.2020.104815
41
Caterina Sagnelli, Evangelista Sagnelli. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factorsWorld Journal of Clinical Infectious Diseases 2019; 9(2): 11-22 doi: 10.5495/wjcid.v9.i2.11
42
Pranatharthi H. Chandrasekar, Miriam T. Levine. Occult Hepatitis B Virus Reactivation in a Seronegative Stem Cell Transplant RecipientInfectious Diseases in Clinical Practice 2017; 25(2): 97 doi: 10.1097/IPC.0000000000000472
43
Evangelista Sagnelli, Loredana Alessio, Caterina Sagnelli, Luciano Gualdieri, Mariantonietta Pisaturo, Carmine Minichini, Giovanni Di Caprio, Mario Starace, Lorenzo Onorato, Margherita Macera, Gaetano Scotto, Nicola Coppola. Hepatitis B Virus Genotypes, Epidemiological Characteristics and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern ItalyHepatitis Monthly 2017; 17(9) doi: 10.5812/hepatmon.13740
44
Bulent Cakal, Alp Atasoy, Bilger Cavus, Mehves Poda, Mesut Bulakci, Mine Gulluoglu, Mehmet Demirci, Filiz Akyuz. Prevalence of Occult Hepatitis B Infection in Liver Biopsy Sample of Patients with Nonviral Liver DiseaseFuture Virology 2022; 17(10): 733 doi: 10.2217/fvl-2021-0316
45
Caterina Sagnelli, Massimo Ciccozzi, Nicola Coppola, Carmine Minichini, Alessandra Lo Presti, Mario Starace, Loredana Alessio, Margherita Macera, Eleonora Cella, Luciano Gualdieri, Nunzio Caprio, Giuseppe Pasquale, Evangelista Sagnelli. Molecular diversity in irregular or refugee immigrant patients with HBV‐genotype‐E infection living in the metropolitan area of NaplesJournal of Medical Virology 2017; 89(6): 1015 doi: 10.1002/jmv.24724